Concepedia

Elisabeth Digifico

ED

Statistics

Publications

4

Citations

311

H-Index

4

Active since

2019

Affiliations

Humanitas University(Current)

IRCCS Humanitas Research Hospital

Istituti di Ricovero e Cura a Carattere Scientifico

Mario Negri Institute for Pharmacological Research

Elisabeth Digifico is an author at Humanitas University specializing in cancer immunotherapy, tumor-associated macrophages, and immunology.

ORCID

Publications per year

2019–2021

4

Publications

4

The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33

Manuela Liguori, Elisabeth Digifico, Alessandro Vacchini et al. · Cellular and Molecular Immunology · 2020 · 127 citations · Full text

, , +13

Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity

Clément Anfray, Francesco Mainini, Elisabeth Digifico et al. · Journal for ImmunoTherapy of Cancer · 2021 · 94 citations · Full text

, , +17

Poly(I:C) stimulation is superior than Imiquimod to induce the antitumoral functional profile of tumor‐conditioned macrophages

Akihiro Maeda, Elisabeth Digifico, Alberto Mantovani et al. · European Journal of Immunology · 2019 · 55 citations · Full text

, , +17

Inhibition of tumor‐associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti‐PD‐1 therapy

Cristina Belgiovine, Roberta Frapolli, Manuela Liguori et al. · European Journal of Immunology · 2021 · 35 citations · Full text

, , +16

1–4 of 4